» Articles » PMID: 17459060

RNA Interference-mediated Signal Transducers and Activators of Transcription 3 Gene Silencing Inhibits Invasion and Metastasis of Human Pancreatic Cancer Cells

Overview
Journal Cancer Sci
Specialty Oncology
Date 2007 Apr 27
PMID 17459060
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Signal transducers and activators of transcription-3 (STAT3), a central cytoplasmic transcription factor, is frequently overexpressed and constitutively activated by tyrosine during malignant transformation. The overexpression and phosphorylation of STAT3 in pancreatic cancer has been described only recently, but the roles and mechanism still remain unclear. In this study, we elucidate the significance of the STAT3 signaling pathway in metastatic potentials of pancreatic cancer. We stably silence the expression of the STAT3 and p-STAT3 by using RNA interference (RNAi) in the pancreatic cancer cell line SW1990, and then reduce its invasion capacity in vitro and metastasis capacity in vivo compared to parental cells or cells tansfected with a control vector. Furthermore, silencing SW1990 cells with the STAT3 gene by RNAi also led to a decrease of matrix metalloproteinases-2 (MMP-2) and vascular endothelial growth factor (VEGF) at the mRNA and protein level. Collectively, these studies suggest that activation of the STAT3 signaling pathway plays an important role in the progression of pancreatic cancer, and that silence of the STAT3 gene with RNAi may be a useful anti-invasive therapeutic option in pancreatic cancer.

Citing Articles

L3MBTL3 and STAT3 collaboratively upregulate SNAIL expression to promote metastasis in female breast cancer.

Xiao J, Wang J, Li J, Xiao J, Liu C, Tan L Nat Commun. 2025; 16(1):231.

PMID: 39747894 PMC: 11696420. DOI: 10.1038/s41467-024-55617-9.


The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.

Zhao R, Hu Z, Zhang X, Huang S, Yu G, Wu Z Cell Commun Signal. 2024; 22(1):68.

PMID: 38273295 PMC: 10809652. DOI: 10.1186/s12964-023-01421-9.


Lipids as Targets for Renal Cell Carcinoma Therapy.

Stepanovska Tanturovska B, Manaila R, Fabbro D, Huwiler A Int J Mol Sci. 2023; 24(4).

PMID: 36834678 PMC: 9963825. DOI: 10.3390/ijms24043272.


STAT3 mediates RCP-induced cancer cell invasion through the NF-κB/Slug/MT1-MMP signaling cascade.

Cho S, Jeong B, Song Y, Park C, Cho D, Lee H Arch Pharm Res. 2022; 45(7):460-474.

PMID: 35809175 DOI: 10.1007/s12272-022-01396-0.


Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.

Shi Y, Tao M, Wang Y, Zang X, Ma X, Qiu A J Pathol. 2019; 250(1):79-94.

PMID: 31579944 PMC: 7481741. DOI: 10.1002/path.5352.


References
1.
Bloomston M, Zervos E, Rosemurgy 2nd A . Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol. 2002; 9(7):668-74. DOI: 10.1007/BF02574483. View

2.
Darnell Jr J . STATs and gene regulation. Science. 1997; 277(5332):1630-5. DOI: 10.1126/science.277.5332.1630. View

3.
Grandis J, Drenning S, Zeng Q, Watkins S, Melhem M, Endo S . Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A. 2000; 97(8):4227-32. PMC: 18206. DOI: 10.1073/pnas.97.8.4227. View

4.
Bowman T, Garcia R, Turkson J, Jove R . STATs in oncogenesis. Oncogene. 2000; 19(21):2474-88. DOI: 10.1038/sj.onc.1203527. View

5.
Uprichard S . The therapeutic potential of RNA interference. FEBS Lett. 2005; 579(26):5996-6007. PMC: 7094730. DOI: 10.1016/j.febslet.2005.08.004. View